Today, Congresswoman Lizzie Fletcher (TX-07) voted against H.R. 2811, House Republicans’ extreme bill that increases the risk of economic disaster for America and Americans.   “The United States must pay its bills, and Congress must make it possible to do so,” said Congresswoman Lizzie Fletcher.  “It is irresponsible to put at risk the full faith and credit of the… Read more »

Today, Congresswoman Lizzie Fletcher (TX-07) released the following statement after the U.S. Supreme Court’s decision in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration (FDA).  Mifepristone is a safe and effective medication used in abortion care, including miscarriage treatment, originally approved for use more than 20 years ago.  It is… Read more »

Today, Congresswoman Lizzie Fletcher (TX-07) voted against the disingenuously named Protection of Women and Girls in Sports Act of 2023, H.R. 734, which bans transgender girls from playing on a school sports team consistent with their gender identity.  The bill also defines sex as based on an individual’s reproductive biology and genetics at birth.    “Participating… Read more »

This week, Congresswoman Lizzie Fletcher (TX-07) delivered remarks at the House Democratic Caucus leadership press conference to highlight Democrats’ commitment to fight abortion pill restrictions in recent court rulings as well as her bill, the Protecting Reproductive Freedom Act, H.R. 2573, which reaffirms that the U.S. Food and Drug Administration (FDA) appropriately approved and… Read more »

Today, Congresswoman Lizzie Fletcher (TX-07) released the following statement after the U.S. Court of Appeals for the Fifth Circuit granted a partial stay of the district court’s order in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration (FDA).  Mifepristone is a safe and effective medication used in abortion care, including miscarriage treatment,… Read more »

Congresswoman Lizzie Fletcher (TX-07) joined 239 other Democratic members of Congress in submitting an amicus brief to the U.S. Court of Appeals for the Fifth Circuit in the case of Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration (FDA).  The brief supports the Biden administration’s appeal of the Northern District of Texas ruling that suspends the… Read more »

Congresswoman Lizzie Fletcher (TX-07), Congressman John Joyce, M.D. (PA-13), Congresswoman Lisa Blunt Rochester (DE-AL) and Congresswoman Elise Stefanik (NY-21) introduced the Strengthening Community Care Act of 2023, H.R. 2559, to reauthorize federal funding for Community Health Centers and the National Health Service Corps through 2028.  Without passing reauthorization… Read more »

Today, Congresswoman Lizzie Fletcher (TX-07) and Congressman Pat Ryan (NY-18) introduced the Protecting Reproductive Freedom Act, to reaffirm that Mifepristone, also known as the abortion pill, was appropriately approved by the U.S. Food and Drug Administration (FDA) and that this approval preempts any state law seeking to prohibit or restrict access to the abortion… Read more »

Today, Congresswoman Lizzie Fletcher (TX-07) released the following statement after Judge Matthew Kacsmaryk of the Northern District of Texas released a decision in Alliance Defending Freedom v. U.S. Food and Drug Administration issuing a preliminary injunction that stays the Food and Drug Administration’s (FDA’s) approval of medication for the termination of… Read more »

Congresswoman Lizzie Fletcher (TX-07) held her first town hall of 2023 at the University of Houston at Sugar Land, where she provided an update on her work for Texas’ Seventh Congressional District and answered constituents’ questions on issues of importance to the community. “I was glad to be together with residents of Texas’ Seventh Congressional District to provide a report on the… Read more »